首页> 外文会议>ASME Bioengineering Conference >SIMULATED DEPLOYMENT OF PERCUTANEOUS TRANSVENOUS MITRAL ANNULOPLASTY DEVICE INTO HUMAN CORONARY SINUS VESSEL
【24h】

SIMULATED DEPLOYMENT OF PERCUTANEOUS TRANSVENOUS MITRAL ANNULOPLASTY DEVICE INTO HUMAN CORONARY SINUS VESSEL

机译:模拟经皮吞咽二尖瓣瓣膜成形术料到人冠状窦血管中的部署

获取原文

摘要

Functional mitral regurgitation (MR) is the consequence of left ventricular dysfunction occurring after ischemic heart disease and often has poor prognosis. Surgical repair and replacement of the mitral valve are currently being used to treat severe functional MR However, the technique carries high mortality rate [1] and is not suitable for patients with comorbidities and advanced age [2]. Recently, a new non-surgical intervention, percutaneous transvenous mitral annuloplasty (PTMA), is emerging as an attractive endovascular alternative that is less invasive, less recovery time, and cost effective. The device is delivered percutaneously into the coronary sinus (CS) vessel and once embedded, it contracts and shortens the septo-lateral distance of the mitral annulus, hence improve MR. However, despite of its feasibility, current clinical trials reported severe adverse events, such as device fracture [3]. The biomechanical interaction between the CS wall and the stent plays a critical role in the outcome of the deployment and the device performance. In this study, we proposed to analyze this interaction by developing Finite Element (FE) models of the CS vessel and the PTMA anchors and analyzing the peak stresses, strains, interaction forces (shear, normal) after the deployment of the proximal and distal anchors into a realistic patient-specific CS model.
机译:功能二尖瓣反流(MR)是缺血性心脏病后发生的左心室功能障碍,并且预后差异差。目前用于治疗严重功能性的二尖瓣手术修复和更换,但该技术携带高死亡率[1],并不适用于患有合并症和晚期的患者[2]。最近,一种新的非外科介入,经皮吞咽二尖瓣倒环成形术(PTMA)被揭示为具有较小侵入性,恢复时间和成本效益的有吸引力的血管内替代品。该装置经皮到冠状动脉窦(CS)容器中,并一旦嵌入,它收缩并缩短二尖瓣环的侧侧距离,因此改善了MIR。然而,尽管其可行性,目前的临床试验报告了严重的不良事件,如装置骨折[3]。 CS墙和支架之间的生物力学相互作用在部署的结果和设备性能方面发挥着关键作用。在该研究中,我们提出通过开发CS血管和PTMA锚点的有限元(Fe)模型来分析该相互作用,并在坐姿部署后分析峰值应力,菌株,相互作用力(剪切,正常)进入一个现实的患者特定的CS模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号